235 related articles for article (PubMed ID: 12825877)
21. Time-resolved immunofluorometric assay of trypsin-1 complexed with alpha(1)-antitrypsin in serum: increased immunoreactivity in patients with biliary tract cancer.
Hedström J; Haglund C; Kemppainen E; Leinimaa M; Leinonen J; Stenman UH
Clin Chem; 1999 Oct; 45(10):1768-73. PubMed ID: 10508123
[TBL] [Abstract][Full Text] [Related]
22. Correlation of trypsin-plasma inhibitor complexes with mortality in experimental pancreatitis in rats.
Largman C; Reidelberger RD; Tsukamoto H
Dig Dis Sci; 1986 Sep; 31(9):961-9. PubMed ID: 3488185
[TBL] [Abstract][Full Text] [Related]
23. Urinary trypsinogen activation peptide (TAP) predicts severity in patients with acute pancreatitis.
Tenner S; Fernandez-del Castillo C; Warshaw A; Steinberg W; Hermon-Taylor J; Valenzuela JE; Hariri M; Hughes M; Banks PA
Int J Pancreatol; 1997 Apr; 21(2):105-10. PubMed ID: 9209951
[TBL] [Abstract][Full Text] [Related]
24. Evidence for extraluminal trypsinogen activation in three different models of acute pancreatitis.
Foitzik T; Lewandrowski KB; Fernández-del Castillo C; Rattner DW; Warshaw AL
Surgery; 1994 Jun; 115(6):698-702. PubMed ID: 8197561
[TBL] [Abstract][Full Text] [Related]
25. Acute pancreatitis in Soweto, South Africa: relationship between trypsinogen load, trypsinogen activation, and fibrinolysis.
Segal I; Chaloner C; Douglas J; John KD; Zaidi A; Cotter L; Appelros S; Borgström A; Braganza JM
Am J Gastroenterol; 2002 Apr; 97(4):883-92. PubMed ID: 12003423
[TBL] [Abstract][Full Text] [Related]
26. Serum trypsinogen-2 and trypsin-2-alpha(1)-antitrypsin complex in malignant and benign digestive-tract diseases. Preferential elevation in patients with cholangiocarcinomas.
Hedström J; Haglund C; Haapiainen R; Stenman UH
Int J Cancer; 1996 May; 66(3):326-31. PubMed ID: 8621252
[TBL] [Abstract][Full Text] [Related]
27. [Trypsinogen activation peptides in acute pancreatitis. Experimental data and clinical implications].
Foitzik T; Fernandez-del Castillo C; Lewandrowski KB; Rattner DW; Herfarth C; Warshaw AL
Chirurg; 1994 Mar; 65(3):186-9. PubMed ID: 8194402
[TBL] [Abstract][Full Text] [Related]
28. Activation peptide of carboxypeptidase B and anionic trypsinogen as early predictors of the severity of acute pancreatitis.
Appelros S; Petersson U; Toh S; Johnson C; Borgström A
Br J Surg; 2001 Feb; 88(2):216-21. PubMed ID: 11167870
[TBL] [Abstract][Full Text] [Related]
29. Serum complex of trypsin 2 and alpha 1 antitrypsin as diagnostic and prognostic marker of acute pancreatitis: clinical study in consecutive patients.
Hedström J; Sainio V; Kemppainen E; Haapiainen R; Kivilaakso E; Schröder T; Leinonen J; Stenman UH
BMJ; 1996 Aug; 313(7053):333-7. PubMed ID: 8760740
[TBL] [Abstract][Full Text] [Related]
30. Serum trypsinogen activation peptide in the assessment of the diagnosis and severity of acute pancreatic damage: a pilot study using a new determination technique.
Pezzilli R; Venturi M; Morselli-Labate AM; Ceciliato R; Lamparelli MG; Rossi A; Moneta D; Piscitelli L; Corinaldesi R
Pancreas; 2004 Nov; 29(4):298-305. PubMed ID: 15502646
[TBL] [Abstract][Full Text] [Related]
31. Interstitial trypsinogen release and its relevance to the transformation of mild into necrotizing pancreatitis in rats.
Hartwig W; Jimenez RE; Werner J; Lewandrowski KB; Warshaw AL; Fernández-del Castillo C
Gastroenterology; 1999 Sep; 117(3):717-25. PubMed ID: 10464149
[TBL] [Abstract][Full Text] [Related]
32. Increased secretion of the pancreatic secretory trypsin inhibitor (PSTI-I, monitor peptide) during development of chronic pancreatitis in the WBN/Kob rat.
Graf R; Schiesser M; Bimmler D
Pancreatology; 2002; 2(2):108-15. PubMed ID: 12123090
[TBL] [Abstract][Full Text] [Related]
33. Predicting the severity of acute pancreatitis by rapid measurement of trypsinogen-2 in urine.
Lempinen M; Kylänpää-Bäck ML; Stenman UH; Puolakkainen P; Haapiainen R; Finne P; Korvuo A; Kemppainen E
Clin Chem; 2001 Dec; 47(12):2103-7. PubMed ID: 11719473
[TBL] [Abstract][Full Text] [Related]
34. Early prediction of severe acute pancreatitis by urinary trypsinogen activation peptide.
Liu ZS; Jiang CQ; Qian Q; Sun Q; Fan LF; Ai ZL
Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):285-9. PubMed ID: 14612286
[TBL] [Abstract][Full Text] [Related]
35. Effect of microcirculatory perfusion on distribution of trypsinogen activation peptides in acute experimental pancreatitis.
Foitzik T; Hotz HG; Schmidt J; Klar E; Warshaw AL; Buhr HJ
Dig Dis Sci; 1995 Oct; 40(10):2184-8. PubMed ID: 7587786
[TBL] [Abstract][Full Text] [Related]
36. Dexamethasone affects inflammation but not trypsinogen activation in experimental acute pancreatitis.
Muller CA; Belyaev O; Appelros S; Buchler M; Uhl W; Borgstrom A
Eur Surg Res; 2008; 40(4):317-24. PubMed ID: 18303267
[TBL] [Abstract][Full Text] [Related]
37. Do plasma and urine trypsinogen activation peptides (TAP) really increase in trypsin-taurocholate-induced pancreatitis?
Wang Y; Naruse S; Kitagawa M; Ishiguro H; Nakae Y; Yoshikawa T; Hayakawa T
Pancreas; 2000 May; 20(4):389-93. PubMed ID: 10824694
[TBL] [Abstract][Full Text] [Related]
38. Ligation-induced acute pancreatitis increases pancreatic circulating trypsinogen activation peptides.
Merriam LT; Wilcockson D; Samuel I; Joehl RJ
J Surg Res; 1996 Feb; 60(2):417-21. PubMed ID: 8598679
[TBL] [Abstract][Full Text] [Related]
39. Intra-acinar cell activation of trypsinogen during caerulein-induced pancreatitis in rats.
Hofbauer B; Saluja AK; Lerch MM; Bhagat L; Bhatia M; Lee HS; Frossard JL; Adler G; Steer ML
Am J Physiol; 1998 Aug; 275(2):G352-62. PubMed ID: 9688663
[TBL] [Abstract][Full Text] [Related]
40. Plasma and urinary trypsinogen activation peptide in healthy dogs, dogs with pancreatitis and dogs with other systemic diseases.
Mansfield CS; Jones BR
Aust Vet J; 2000 Jun; 78(6):416-22. PubMed ID: 10920782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
